At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Fractionated Stereotactic Radiosurgeryradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES
In Brief
A clinical study evaluating Fractionated Stereotactic Radiosurgery for Large Brain Mets. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This is a research trial that seeks to break up the total radiation dose into multiple smaller radiation treatments, termed fractionated stereotactic radiosurgery (FSRS) which may make the treatment feasible. Fractionated sterotatcic radiation, the risks of FSRS, and possible costs will be described later in this document. This clinical trial is for people who have had no prior whole brain radiation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLarge Brain Mets
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedFeb 2014
Primary CompletionNov 2017
Study CompletionMar 2023
TodayJul 2026
First PostedFeb 4, 2014
Enrollment StartJul 16, 2013
Primary CompletionNov 20, 2017
Study CompletionMar 9, 2023
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.4 years ago
Interventions
Fractionated Stereotactic Radiosurgeryradiation
SRS SBRT CyberKnife Trilogy True Beam Radiosurgery